HEPATITIS-B INFECTION IN SUB-SAHARAN AFRICA

被引:43
|
作者
KIIRE, CF
机构
关键词
epidemiology; Hepatitis B; sub-Saharan Africa; vaccination;
D O I
10.1016/0264-410X(90)90229-F
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Hepatitis B virus (HBV) infection and its sequelae are extremely common in sub-Saharan Africa. The overall hepatitis B surface antigen (HBsAg) carrier rate in the general population is 5-20%, which is amongst the highest in the world. Although perinatal infection occurs with an incidence of 1-5%, the predominant form of transition is horizontal among infants and young children; most infections are acquired between 6 months and the pre-school age (5-6 years). Thus, the traditional concept of 'high-risk groups' is limited importance in Africa and all children should be regarded as being at risk. Hepatitis B-associated hepatocellular carcinoma is probably the most common tumour affecting males in sub-Saharan Africa, with Mozambique having the highest incidence rate of 103.8 per 100 000 males. Cost-benefit analysis shows that, in sub-Saharan Africa, the most effective way of controlling hepatitis B infection is through mass neonatl vaccination programmes integrated within the Expanded Programme on Immunization without prior testing for HBV markers. © 1990.
引用
收藏
页码:S107 / S112
页数:6
相关论文
共 50 条
  • [21] Hepatitis B virus (HBV) infection in Sub-Saharan immigrants in Almeria (Spain)
    Salas, Joaquin
    Vazquez, Jose
    Cabezas, Teresa
    Belen Lozano, Ana
    Cabeza, Isabel
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2011, 29 (02): : 121 - 123
  • [22] TUBERCULOSIS AND HIV-INFECTION IN SUB-SAHARAN AFRICA
    DECOCK, KM
    SORO, B
    COULIBALY, IM
    LUCAS, SB
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (12): : 1581 - 1587
  • [23] OCCURRENCE OF HUMAN CYCLOSPORA INFECTION IN SUB-SAHARAN AFRICA
    MARKUS, MB
    FREAN, JA
    SOUTH AFRICAN MEDICAL JOURNAL, 1993, 83 (11): : 862 - 863
  • [24] Community-based screening and treatment for chronic hepatitis B in sub-Saharan Africa
    Qin, Gang
    Shao, Jian-Guo
    LANCET GLOBAL HEALTH, 2017, 5 (01): : E34 - E34
  • [25] Screen-and-treat for chronic hepatitis B: an overdue issue for sub-Saharan Africa
    Allain, Jean-Pierre
    LANCET GLOBAL HEALTH, 2016, 4 (08): : E507 - E508
  • [26] Identifying patients infected with hepatitis B virus in sub-Saharan Africa: potential for misclassification
    Boyd, Anders
    Maylin, Sarah
    Moh, Raoul
    Gabillard, Delphine
    Menan, Herve
    Mahjoub, Nadia
    Danel, Christine
    Anglaret, Xavier
    Eholie, Serge Paul
    Girard, Pierre-Marie
    Zoulim, Fabien
    Delaugerre, Constance
    Lacombe, Karine
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2015, 83 (03) : 248 - 251
  • [27] Non-invasive fibrosis markers for chronic hepatitis B in sub-Saharan Africa
    Huang, Rui
    Jia, Bei
    Wang, Guiyang
    Wu, Chao
    LIVER INTERNATIONAL, 2017, 37 (11) : 1738 - 1738
  • [28] Hepatitis B in sub-Saharan Africa-How many patients need therapy?
    Sonderup, Mark W.
    Dusheiko, Geoffrey
    Desalegn, Hailemichael
    Lemoine, Maud
    Tzeuton, Christian
    Taylor-Robinson, Simon D.
    Spearman, C. Wendy
    JOURNAL OF VIRAL HEPATITIS, 2020, 27 (06) : 560 - 567
  • [29] Hepatitis C in Sub-Saharan Africa: Urgent Need for Attention
    Layden, Jennifer E.
    Phillips, Richard
    Opare-Sem, Ohene
    Akere, Adegboyega
    Salako, Babatunde L.
    Nelson, Kenrad
    Dugas, Lara
    Luke, Amy
    Tayo, Bamidele O.
    Cooper, Richard S.
    OPEN FORUM INFECTIOUS DISEASES, 2014, 1 (02):
  • [30] The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: A view from tropical and subtropical Africa - Discussion
    Zuckerman
    Kiire
    Kew
    Goudeau
    Hollinger
    Yao
    Gust
    Toukan
    Lansang
    Ahn
    GUT, 1996, 38 : S11 - S12